Aura Biosciences (AURA) Other financing activities (2020 - 2026)

Aura Biosciences' Other financing activities history runs 7 years deep, the most recent figure standing at $123000.0 for Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 10.08% YoY) and the FY2025 annual result came in at $1.0 million, down 28.77% from the prior year.
• Other financing activities was $123000.0 for Q1 2026 at Aura Biosciences, up from -$13.1 million in the prior quarter.
• Across five years, Other financing activities topped out at $14.2 million in Q2 2025 and bottomed at -$13.1 million in Q3 2025.
• A 5-year average of $239153.8 and a median of $123000.0 in 2026 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 22569.84% in 2025, while the deepest fall reached 1785.38% in 2025.
• Aura Biosciences' Other financing activities stood at $104000.0 in 2022, then sank by 30.77% to $72000.0 in 2023, then soared by 654.17% to $543000.0 in 2024, then plunged by 2520.99% to -$13.1 million in 2025, then soared by 100.94% to $123000.0 in 2026.
• Business Quant data shows AURA's Other financing activities at $123000.0 in Q1 2026, -$13.1 million in Q3 2025, and $14.2 million in Q2 2025.